Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04921787 · ClinicalTrials.gov registry record · NA
EXHIT ENTRE Implementation Trial of High Intensity Versus Low Intensity Strategy
A NA study of Substance Use Disorders and Opioid Use Disorder, Moderate, sponsored by Gavin Bart.
- Active
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 4
- Study locations
NCT04921787: Active NA study of Substance Use Disorders and Opioid Use Disorder, Moderate, sponsored by Gavin Bart.
NCT04921787 is a NA study of Substance Use Disorders and Opioid Use Disorder, Moderate that is active but no longer recruiting, run by Gavin Bart. The registered enrollment target is 24 participants, below the 500-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (95% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04921787, a NA study of Substance Use Disorders and Opioid Use Disorder, Moderate, is active but no longer recruiting, sponsored by Gavin Bart.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 4
- Study locations
Study Summary
This study is a multi-site, cluster randomized, two group implementation trial comparing a low- versus high-intensity implementation strategy for supporting hospital-based opioid use disorder treatment (HBOT) in community hospital settings where medication for opioid use disorder (MOUD) treatment has not been implemented.
Primary Outcome
measured as the proportion of community hospital OUD discharges engaged with MOUD within 34 days following hospital discharge during months 13-24 of the intervention.
Conditions Studied
Interventions
- OTHER Low Intensity
- OTHER High Intensity
Study Locations (4)
Massachusetts
- Boston University - Boston
Minnesota
- Hennepin Healthcare Research Institute - Minneapolis
New York
- New York University - New York
Oregon
- Oregon Health & Science University - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2021-10-22 |
| Est. Completion | 2026-02-28 |
| Phase | NA |
What the registry record for NCT04921787 still lists
NCT04921787 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 500-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (95% lower).
The record links to 3 conditions, with Substance Use Disorders appearing as the primary indexed condition, and to 2 interventions - of which Low Intensity is the first listed.
NCT04921787 reports a single indexed study location in Massachusetts, Minnesota, New York.
Frequently Asked Questions
What is clinical trial NCT04921787 about?
NCT04921787 is a clinical study titled "EXHIT ENTRE Implementation Trial of High Intensity Versus Low Intensity Strategy". This study is a multi-site, cluster randomized, two group implementation trial comparing a low- versus high-intensity implementation strategy for supporting hospital-based opioid use disorder treatment (HBOT) in community hospital settings where medication for opioid use disorder (MOUD) treatment ha...
What is the current status of trial NCT04921787?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2021-10-22. Estimated completion is 2026-02-28.
What conditions does trial NCT04921787 study?
This clinical trial studies the following conditions: Substance Use Disorders, Opioid Use Disorder, Moderate, Opioid Use Disorder, Severe.
What interventions are being tested in trial NCT04921787?
The interventions under investigation include: Low Intensity (OTHER), High Intensity (OTHER).
Who is sponsoring clinical trial NCT04921787?
This trial is sponsored by Gavin Bart, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04921787 being conducted?
This trial has 4 study locations across Massachusetts, Minnesota, New York, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Use Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04921787's enrollment target sits among peer trials
24 84th of 93 higher than 8 of 93 other Substance Use Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance Use Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Supporting Treatment Access and Recovery Through Linkage and Support
RECRUITING · NA
-
Development OF A Novel Peer Recovery Supporter Training Platform
RECRUITING · NA
-
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
RECRUITING · NA
-
Testing Strategies to Improve Substance Misuse Prevention Research Use in State Policy Contexts
RECRUITING · NA
-
Families Left Behind
RECRUITING · NA
-
Trauma Screening/Referral and Interpersonal Violence Prevention for Women with Substance Use Disorders
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI